CDKN1A and neoplasm: The analysis revealed a clear separation of CRC primary tumor samples, regarding survival when performing the risk prediction in the set of 167 CMS1 patients with the 40 upregulated genes in HCT116 p21-/- cells from our gene signature (Figure 5A–D).